MOLECULARHEALTH Trademark

Trademark Overview


On Thursday, March 29, 2012, a trademark application was filed for MOLECULARHEALTH with the United States Patent and Trademark Office. The USPTO has given the MOLECULARHEALTH trademark a serial number of 85583366. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Wednesday, June 7, 2023. This trademark is owned by Molecular Health AG. The MOLECULARHEALTH trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing an online database featuring medical information and diagnostic, prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols

Data collection for medical and scientific research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient-specific molecular and genomic data, patient specific clinical data and scientific clinical studies; data collection for medical and scientific research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and...
molecularhealth

General Information


Serial Number85583366
Word MarkMOLECULARHEALTH
Filing DateThursday, March 29, 2012
Status701 - SECTION 8 - ACCEPTED
Status DateWednesday, June 7, 2023
Registration Number4975047
Registration DateTuesday, June 7, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkMOLECULAR HEALTH
Goods and ServicesProviding an online database featuring medical information and diagnostic, prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols
Goods and ServicesData collection for medical and scientific research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient-specific molecular and genomic data, patient specific clinical data and scientific clinical studies; data collection for medical and scientific research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical treatment research; design and development of databases featuring biomarker data; providing an online searchable database for clinical and scientific research in the field of medical, diagnostic and treatment research; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others; consulting services in the field of pharmaceuticals and genetics, namely, conducting drug safety and dosage assessment and in drug compatibility studies in the field of cancer treatment therapy for others relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing online non-downloadable computer software for use by healthcare professionals for medical diagnostics

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 4, 2012
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 4, 2012
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMOLECULAR HEALTH GMBH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHEIDELBERG 69115
DE

Party NameMOLECULAR HEALTH GMBH
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressHEIDELBERG 69115
DE

Party NameMolecular Health AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address4010 Basel
CH

Trademark Events


Event DateEvent Description
Wednesday, June 7, 2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Wednesday, June 7, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, June 5, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, December 17, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, December 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, December 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, December 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, December 17, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 6, 2022TEAS SECTION 8 RECEIVED
Monday, June 7, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 7, 2016REGISTERED-SUPPLEMENTAL REGISTER
Thursday, May 5, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 28, 2016APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, April 27, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, April 27, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 27, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, April 27, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 26, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 29, 2016WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, March 11, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 8, 2016APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, March 4, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 3, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 3, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 21, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 21, 2015NON-FINAL ACTION E-MAILED
Monday, December 21, 2015NON-FINAL ACTION WRITTEN
Wednesday, December 9, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 9, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 30, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 19, 2015ASSIGNED TO EXAMINER
Sunday, May 31, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, May 31, 2015NON-FINAL ACTION E-MAILED
Sunday, May 31, 2015NON-FINAL ACTION WRITTEN
Wednesday, May 6, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 6, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 28, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 29, 2014NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, October 29, 2014INQUIRY TO SUSPENSION E-MAILED
Wednesday, October 29, 2014SUSPENSION INQUIRY WRITTEN
Tuesday, October 7, 2014SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, August 20, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, April 7, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 7, 2014LETTER OF SUSPENSION E-MAILED
Monday, April 7, 2014SUSPENSION LETTER WRITTEN
Thursday, March 20, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 20, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 14, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, October 4, 2013NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, October 4, 2013INQUIRY TO SUSPENSION E-MAILED
Friday, October 4, 2013SUSPENSION INQUIRY WRITTEN
Thursday, September 19, 2013SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, March 18, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 18, 2013LETTER OF SUSPENSION E-MAILED
Monday, March 18, 2013SUSPENSION LETTER WRITTEN
Thursday, March 7, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, March 7, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 7, 2013EXAMINERS AMENDMENT E-MAILED
Thursday, March 7, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, January 31, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 31, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 24, 2013ASSIGNED TO LIE
Tuesday, January 22, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 22, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, July 22, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, July 22, 2012NON-FINAL ACTION E-MAILED
Sunday, July 22, 2012NON-FINAL ACTION WRITTEN
Tuesday, July 10, 2012ASSIGNED TO EXAMINER
Thursday, April 5, 2012NOTICE OF PSEUDO MARK MAILED
Wednesday, April 4, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 2, 2012NEW APPLICATION ENTERED